XML 23 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stockholders' Equity
6 Months Ended
Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stockholders' Equity
Stockholders’ Equity
Shares Reserved for Future Issuance
The following shares of common stock were reserved for future issuance as of June 30, 2016:
 
Common stock options outstanding
6,937,798

Common stock available for future grant under 2012 Equity Incentive Plan
2,164,263

Common stock available for future grant under 2015 Inducement Plan
581,806

Employee Stock Purchase Plan
1,697,431

Total common shares reserved for future issuance
11,381,298


The following table summarizes our stock option activity under all equity incentive plans for the six months ended June 30, 2016 (shares in thousands): 
 
Number of
options
 
Weighted
average
exercise
price
Options outstanding at December 31, 2015
5,126

 
$
8.91

Granted
2,375

 
$
6.62

Exercised
(56
)
 
$
4.76

Canceled/forfeited/expired
(507
)
 
$
10.47

Options outstanding at June 30, 2016
6,938

 
$
8.04


Stock-Based Compensation
The following table summarizes the weighted average assumptions used to estimate the fair value of stock options and performance stock awards granted to employees under our 2012 Equity Incentive Plan and 2015 Inducement Plan and the shares purchasable under our Employee Stock Purchase Plan during the periods presented:
 
 
Three months ended
June 30,
 
Six months ended
June 30,
 
2016
 
2015
 
2016
 
2015
Stock options
 
 
 
 
 
 
 
Risk-free interest rate
1.5
%
 
1.8
%
 
1.4
%
 
1.8
%
Volatility
79.1
%
 
79.1
%
 
79.7
%
 
78.8
%
Dividend yield

 

 

 

Expected term (years)
5.8

 
6.1

 
5.9

 
6.1

Performance stock options
 
 
 
Risk-free interest rate
0.4
%
 

 
1.4
%
 
1.8
%
Volatility
78.5
%
 

 
79.3
%
 
76.4
%
Dividend yield

 

 

 

Expected term (years)
5.5

 
0

 
6.0

 
6.0

Employee stock purchase plan shares
 
 
 
Risk-free interest rate
0.5
%
 
0.1
%
 
0.4
%
 
0.1
%
Volatility
82.6
%
 
76.9
%
 
81.0
%
 
74.9
%
Dividend yield

 

 

 

Expected term (years)
0.5

 
0.5

 
0.5

 
0.5


The following table summarizes the allocation of our stock-based compensation expense for all stock awards during the periods presented (in thousands): 
 
Three months ended
June 30,
 
Six months ended
June 30,
 
2016
 
2015
 
2016
 
2015
Research and development
$
1,299

 
$
3,496

 
$
2,731

 
$
5,452

General and administrative
939

 
2,373

 
3,255

 
3,520

Total
$
2,238

 
$
5,869

 
$
5,986

 
$
8,972